Skip to main content

Phase I study of Pomolidomide, Bortezomib, and Dexamethasone (PVD) as First-Line treatment of AL Amyloidosis or Light Chain Deposition Disease

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Karmanos Cancer Center

Start Date

June 1, 2014

End Date

December 1, 2021
 

Administered By

Duke Cancer Institute

Awarded By

Karmanos Cancer Center

Start Date

June 1, 2014

End Date

December 1, 2021